X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
beta-alanine - analogs & derivatives (1908) 1908
humans (1547) 1547
dabigatran (1040) 1040
male (801) 801
animals (639) 639
beta-alanine - therapeutic use (624) 624
female (622) 622
benzimidazoles - therapeutic use (601) 601
benzimidazoles - adverse effects (517) 517
beta-alanine - adverse effects (494) 494
beta-alanine - pharmacology (461) 461
rivaroxaban (446) 446
anticoagulants - therapeutic use (434) 434
warfarin (431) 431
beta-alanine - administration & dosage (416) 416
atrial fibrillation - drug therapy (390) 390
aged (385) 385
benzimidazoles - administration & dosage (379) 379
stroke - prevention & control (337) 337
anticoagulants - adverse effects (325) 325
anticoagulants (311) 311
administration, oral (304) 304
anticoagulants - administration & dosage (289) 289
atrial fibrillation (284) 284
thiophenes - therapeutic use (282) 282
morpholines - therapeutic use (277) 277
rats (266) 266
middle aged (264) 264
atrial fibrillation - complications (260) 260
hemorrhage - chemically induced (245) 245
warfarin - therapeutic use (238) 238
beta-alanine - metabolism (236) 236
abridged index medicus (223) 223
antithrombins - adverse effects (220) 220
cardiac & cardiovascular systems (220) 220
biochemistry & molecular biology (215) 215
pyrazoles - therapeutic use (215) 215
pyridones - therapeutic use (214) 214
antithrombins - therapeutic use (203) 203
pharmacology & pharmacy (203) 203
stroke (202) 202
beta-alanine - chemistry (193) 193
peripheral vascular disease (192) 192
treatment outcome (192) 192
dabigatran etexilate (187) 187
aged, 80 and over (185) 185
atrial-fibrillation (185) 185
beta-alanine (185) 185
medicine, general & internal (183) 183
stroke - etiology (178) 178
kinetics (168) 168
mice (167) 167
hematology (165) 165
beta-alanine - pharmacokinetics (164) 164
warfarin - adverse effects (164) 164
etexilate (162) 162
prevention (156) 156
morpholines - adverse effects (152) 152
thiophenes - adverse effects (152) 152
adult (151) 151
venous thromboembolism (151) 151
morpholines - administration & dosage (150) 150
risk factors (150) 150
thiophenes - administration & dosage (150) 150
antithrombins - administration & dosage (149) 149
apixaban (136) 136
dose-response relationship, drug (134) 134
neurosciences (129) 129
thrombin (127) 127
direct thrombin inhibitor (125) 125
thromboembolism - prevention & control (125) 125
anticoagulation (124) 124
analysis (116) 116
warfarin - administration & dosage (114) 114
benzimidazoles - pharmacology (111) 111
pyrazoles - administration & dosage (111) 111
risk (111) 111
pyridones - administration & dosage (109) 109
drug therapy (107) 107
alanine - analogs & derivatives (106) 106
therapy (105) 105
pyrazoles - adverse effects (103) 103
time factors (102) 102
pyridones - adverse effects (101) 101
pharmacokinetics (99) 99
amino acids (97) 97
stroke prevention (97) 97
management (96) 96
thromboembolism (94) 94
surgery (92) 92
randomized controlled trials as topic (88) 88
venous thromboembolism - prevention & control (88) 88
research (86) 86
benzimidazoles - pharmacokinetics (84) 84
blood coagulation - drug effects (84) 84
beta-alanine - blood (83) 83
risk assessment (83) 83
factor xa inhibitors (80) 80
drug interactions (77) 77
metabolism (77) 77
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2147) 2147
Japanese (84) 84
German (47) 47
French (31) 31
Spanish (31) 31
Russian (22) 22
Chinese (7) 7
Italian (7) 7
Danish (5) 5
Finnish (5) 5
Hungarian (4) 4
Czech (3) 3
Polish (3) 3
Swedish (2) 2
Dutch (1) 1
Norwegian (1) 1
Portuguese (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
European heart journal, ISSN 1522-9645, 2011, Volume 32, Issue 22, pp. 2781 - 2789
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2014, Volume 30, Issue 10, pp. 1114 - 1130
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2011, Volume 105, Issue 4, pp. 721 - 729
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus subcutaneous enoxaparin for extended thromboprophylaxis in... 
Dabigatran etexilate | Oral anticoagulant | Total hip arthroplasty | Venous thromboembolism | Prophylaxis | SURGERY | DIRECT THROMBIN INHIBITOR | FONDAPARINUX | oral anticoagulant | PREVENTION | DEEP-VEIN THROMBOSIS | prophylaxis | total hip arthroplasty | KNEE REPLACEMENT | venous thromboembolism | MOLECULAR-WEIGHT HEPARIN | ETEXILATE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Antithrombins - administration & dosage | Dabigatran | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Benzimidazoles - administration & dosage | Hemorrhage - etiology | Injections, Subcutaneous | Female | Venous Thrombosis - prevention & control | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Postoperative Complications | beta-Alanine - adverse effects | Double-Blind Method | Administration, Oral | Venous Thrombosis - mortality | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Venous Thrombosis - etiology | Venous Thromboembolism - etiology | Antithrombins - adverse effects | Survival Analysis | Arthroplasty, Replacement, Hip - mortality | Aged | Benzimidazoles | Venous Thrombosis | Oral | Hemorrhage | Antithrombins | Venous Thromboembolism | administration & dosage | Surgery | beta-Alanine | Administration | Anticoagulants | Subcutaneous | Enoxaparin | Arthroplasty | Replacement | prevention & control | Kirurgi | Hip | etiology | Injections | analogs & derivatives | adverse effects | mortality
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 6, pp. 511 - 520
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2020, Issue 6, p. CD006650
Journal Article